Search bioRxiv⌕ Search

Biology subjects

Sreekumar, E.

Publications and source records attributed to Sreekumar, E..

2 recordsLinked to original sources

Utility of recombinant envelope domain III as a diagnostic antigen for the specific detection of Kyasanur Forest Disease

Kyasanur Forest Disease (KFD), commonly known as "monkey fever," is a highly neglected tropical disease caused by the Kyasanur Forest Disease Virus (KFDV). KFD is endemic to Western Ghats of Karnataka, India, with seasonal outbreaks during December to June every year. As there is no standard treatment regime, KFD can be fatal with a mortality rate of 2-10%. Currently, KFD is detected through a non-specific IgM-ELISA followed by RT-PCR, which often delays diagnosis, leading to increased disease severity and even death. To address this, we focused on developing a specific antigen-based KFD detection. The KFDV Envelope Domain III (EDIII) and Non-Structural 1 (NS1) proteins were chosen as detection markers, cloned, and expressed using pET28a(+) vector in BL-21 (Rosetta) E. coli and purified. These proteins were used to raise polyclonal antibodies in rabbits and the antibody titre was found to be 1:256,000 and 1:512,000 against rEDIII and rNS1 proteins, respectively. Importantly, these polyclonal antibodies showed no cross-reactivity against corresponding dengue virus EDIII and NS1 proteins. Using polyclonal antibodies against rEDIII, we developed sandwich ELISA for the specific detection of KFD, which has demonstrated high specificity and sensitivity. Further, anti-rEDIII polyclonal antibodies also detected full-length KFDV-E protein expressed in mammalian cells, confirming the antibody specificity for the native viral antigen.

microbiology↗

Reproducible generation of Nipah virus pseudovirions with uniform expression of F and G surface glycoproteins for high-throughput neutralization assays

Nipah virus (NiV) is a pathogen to be handled in BSL-4 facilities. Multiple surrogate systems such as virus-like particles (VLPs) and pseudoviruses enable carrying out NiV neutralization assays and study of virus entry pathways in biosafety level-2 (BSL-2) facilities. These are dual protein expression and surface display systems comprising NiV structural glycoproteins F and G as the key components. During generation of NiV VLPs or pseudovirions, ensuring batch to batch uniformity is a major concern due to the lack of proportionate expression of these proteins in the producer cells as well as their consistent incorporation in the particles. We established HEK293 pseudovirion producer cells that stably co-express NiV F and G proteins to address the issue. Fluorescence-activated cell sorting (FACS) analysis of clonally selected cells for high and uniform level F and G protein co-expression; and their further expansion were carried out to further refine the system. High titer vesicular stomatitis virus (VSV)-based pseudoviruses which showed consistent expression of both the glycoprotein were reproducibly generated from these producer cells. In functional assays, these pseudovirions exhibited a dose-dependent neutralization by commercial anti-NiV F and G antibodies as well as by convalescent serum from Nipah recovered patients. A pseudovirus neutralization test (PVNT) with a secreted alkaline phosphatase (SEAP) as the reporter was established in the study. The assay supports high-throughput adaptability with a quick turn-around time. It will aid large-scale human and animal serosurveillance studies in Nipah endemic regions as well as screening of virus entry inhibitors and monoclonal antibodies.

microbiology↗